Open AccessPioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Author(s) -
ChinHsiao Tseng
Publication year - 2022
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s345796
Subject(s) - pioglitazone , medicine , copd , hazard ratio , retrospective cohort study , diabetes mellitus , proportional hazards model , cumulative incidence , type 2 diabetes mellitus , cohort study , cohort , confidence interval , type 2 diabetes , endocrinology
Pioglitazone's effect on chronic obstructive pulmonary disease (COPD) has rarely been studied.